These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 7447418
21. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB, Korea INfectious Diseases (KIND) study group. Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202 [Abstract] [Full Text] [Related]
22. Serum bactericidal titer as a predictor of outcome in endocarditis. Hackbarth CJ, Chambers HF, Sande MA. Eur J Clin Microbiol; 1986 Feb; 5(1):93-7. PubMed ID: 2938947 [Abstract] [Full Text] [Related]
23. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Archer GL, Vazquez GJ, Johnston JL. J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687 [Abstract] [Full Text] [Related]
24. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Youngster I, Shenoy ES, Hooper DC, Nelson SB. Clin Infect Dis; 2014 Aug 01; 59(3):369-75. PubMed ID: 24785233 [Abstract] [Full Text] [Related]
25. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Twilla JD, Algrim A, Adams EH, Samarin M, Cummings C, Finch CK. Am J Med Sci; 2020 Jul 01; 360(1):35-41. PubMed ID: 32376001 [Abstract] [Full Text] [Related]
26. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Miller MH, Wexler MA, Steigbigel NH. Antimicrob Agents Chemother; 1978 Sep 01; 14(3):336-43. PubMed ID: 251069 [Abstract] [Full Text] [Related]
27. Comparison of ceftazidime, cefuroxime and methicillin in the treatment of Staphylococcus aureus endocarditis in rabbits. McColm AA, Ryan DM, Acred P. J Antimicrob Chemother; 1984 Oct 01; 14(4):373-7. PubMed ID: 6389474 [Abstract] [Full Text] [Related]
28. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA. J Infect Dis; 1984 Jun 01; 149(6):894-903. PubMed ID: 6564133 [Abstract] [Full Text] [Related]
29. Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply. Herrera-Hidalgo L, de Alarcón A. Int J Infect Dis; 2024 May 01; 142():106979. PubMed ID: 38401779 [No Abstract] [Full Text] [Related]
30. Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial. Wallace RJ, Martin RR, Quinones FJ, Greenberg SB. Antimicrob Agents Chemother; 1981 Nov 01; 20(5):648-52. PubMed ID: 7034641 [Abstract] [Full Text] [Related]
32. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation. Chapman SW, Steigbigel RT. J Infect Dis; 1983 Jun 01; 147(6):1078-89. PubMed ID: 6602190 [Abstract] [Full Text] [Related]
33. Cefazolin and Staphylococcus aureus endocarditis. Kaye D, Hewitt W, Remington JS, Turck M. JAMA; 1977 Jun 13; 237(24):2601. PubMed ID: 576979 [No Abstract] [Full Text] [Related]
34. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Cunha BA, Hamid N, Kessler H, Parchuri S. Heart Lung; 2005 Jun 13; 34(6):442-7. PubMed ID: 16324966 [Abstract] [Full Text] [Related]
35. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis. Boscia JA, Kobasa WD, Kaye D. Antimicrob Agents Chemother; 1988 Feb 13; 32(2):262-4. PubMed ID: 3163241 [Abstract] [Full Text] [Related]
36. Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics. Vouillamoz J, Entenza JM, Féger C, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2000 Jul 13; 44(7):1789-95. PubMed ID: 10858332 [Abstract] [Full Text] [Related]
37. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Levine DP, Cushing RD, Jui J, Brown WJ. Ann Intern Med; 1982 Sep 13; 97(3):330-8. PubMed ID: 7114630 [Abstract] [Full Text] [Related]
38. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Greenman RL, Arcey SM, Gutterman DA, Zweig RM. Antimicrob Agents Chemother; 1984 Jan 13; 25(1):16-9. PubMed ID: 6703681 [Abstract] [Full Text] [Related]
39. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis. Gavaldà J, López P, Martín T, Gomis X, Ramírez JL, Azuaje C, Almirante B, Pahissa A. Antimicrob Agents Chemother; 2002 Feb 13; 46(2):378-84. PubMed ID: 11796345 [Abstract] [Full Text] [Related]
40. The role of vancomycin in the treatment paradigm. Stevens DL. Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]